| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,943,000 | 2,502,000 | 2,894,000 | 2,765,000 | | Cost of Revenue | 159,000 | 3,917,000 | (181,000) | 1,928,000 | | | Gross Profit | 1,784,000 | (1,415,000) | 3,075,000 | 837,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,194,000 | (2,293,000) | 1,839,000 | (161,000) | | Non Recurring |
-
| (141,000) | 141,000 |
-
| | Others | 207,000 | 206,000 | 201,000 | 199,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 383,000 | 813,000 | 894,000 | 799,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,000 | (11,000) | 39,000 | 46,000 | | Earnings Before Interest And Taxes | 400,000 | 831,000 | 933,000 | 845,000 | | Interest Expense | 117,000 | 112,000 | 111,000 | 112,000 | | Income Before Tax | 283,000 | 719,000 | 822,000 | 733,000 | | Income Tax Expense | 106,000 | 267,000 | 302,000 | 280,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 177,000 | 452,000 | 520,000 | 453,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 177,000 | 452,000 | 520,000 | 453,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $177,000 | $452,000 | $520,000 | $453,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
